BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2582209)

  • 41. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
    Chetty R
    Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thoracic neuroendocrine tumors].
    Brambilla E; Lantuejoul S
    Ann Pathol; 2005 Dec; 25(6):529-44. PubMed ID: 16735977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large cell neuroendocrine tumors of the lung. Clinical significance and histopathologic definition.
    Hammond ME; Sause WT
    Cancer; 1985 Oct; 56(7):1624-9. PubMed ID: 2992742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
    Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
    Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The unusual spectrum of neuroendocrine lung neoplasms.
    Hammar S; Bockus D; Remington F; Cooper L
    Ultrastruct Pathol; 1989; 13(5-6):515-60. PubMed ID: 2552631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.
    den Bakker MA; Thunnissen FB
    J Clin Pathol; 2013 Oct; 66(10):862-9. PubMed ID: 23685279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroendocrine neoplasms of the lung.
    Benfield JR
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):628-9. PubMed ID: 2170773
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumors of the diffuse endocrine system, histochemical and electron-optic aids, and pitfalls in diagnosis.
    Silva EG
    Crit Rev Clin Lab Sci; 1984; 21(1):19-49. PubMed ID: 6207987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroendocrine tumours in the respiratory tract.
    de Bruïne AP; Bosman FT
    Acta Histochem Suppl; 1990; 38():99-105. PubMed ID: 1964229
    [No Abstract]   [Full Text] [Related]  

  • 54. [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].
    Schnabel PA; Junker K
    Pathologe; 2014 Nov; 35(6):557-64. PubMed ID: 25366372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Terminology and classification of neuroendocrine neoplasms of the larynx.
    Lewis JS; Ferlito A; Gnepp DR; Rinaldo A; Devaney KO; Silver CE; Travis WD;
    Laryngoscope; 2011 Jun; 121(6):1187-93. PubMed ID: 21557244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine carcinoma of the larynx.
    Porto DP; Wick MR; Ewing SL; Adams GL
    Am J Otolaryngol; 1987; 8(2):97-104. PubMed ID: 2438956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical implications of lung neuroendocrine neoplasm classification.
    Metovic J; Barella M; Harari S; Pattini L; Albini A; Sonzogni A; Veronesi G; Papotti M; Pelosi G
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):377-387. PubMed ID: 33306420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.
    Schmid K; Angerstein N; Geleff S; Gschwendtner A
    Mod Pathol; 2006 Mar; 19(3):453-9. PubMed ID: 16462732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.
    Gridelli C; Rossi A; Airoma G; Bianco R; Costanzo R; Daniele B; Chiara GD; Grimaldi G; Irtelli L; Maione P; Morabito A; Piantedosi FV; Riccardi F
    Cancer Treat Rev; 2013 Aug; 39(5):466-72. PubMed ID: 22818212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.